How is sex‑hormone‑binding globulin (SHBG) used in diagnosing testosterone deficiency (hypogonadism)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

SHBG in Diagnosing Testosterone Deficiency

SHBG measurement is essential when total testosterone is borderline (200-400 ng/dL) or when conditions that alter SHBG levels are present, because total testosterone alone can miss hypogonadism in men with elevated SHBG and can falsely diagnose it in men with low SHBG. 1, 2

When to Measure SHBG

The 2025 EAU guidelines and 2018 Endocrine Society guidelines specify that free testosterone assessment (which requires SHBG measurement) is indicated in:

High SHBG Conditions:

  • Aging (especially men >60 years)
  • HIV/AIDS
  • Cirrhosis and hepatitis
  • Hyperthyroidism
  • Use of anticonvulsants or estrogens
  • SHBG gene polymorphisms 1, 2

Low SHBG Conditions:

  • Obesity
  • Type 2 diabetes/metabolic syndrome
  • Hypothyroidism
  • Acromegaly
  • Cushing's disease
  • Use of glucocorticoids, progestins, or androgenic steroids
  • Nephrotic syndrome 1, 2

Borderline Total Testosterone:

  • When total testosterone is 200-400 ng/dL (7-14 nmol/L), SHBG measurement is mandatory to calculate free testosterone 2

The Clinical Problem with Total Testosterone Alone

Total testosterone measurement has poor specificity and can miss up to 17-26% of hypogonadal men, particularly those over 60 years old. 3 Recent evidence demonstrates:

  • Men with normal total testosterone (>345 ng/dL) but low free testosterone represent 17.2% of ED patients, rising to 26.3% in men over 60 3
  • Total testosterone must exceed 350-400 ng/dL to reliably predict normal free testosterone (sensitivity 96.8-98.2%) 4
  • In men with markedly elevated SHBG, total testosterone can be above the reference range (>916 ng/dL) while free testosterone remains unequivocally low, with elevated LH/FSH confirming primary hypogonadism 5

Diagnostic Algorithm

Step 1: Measure morning total testosterone in symptomatic men (avoid during acute illness) 1, 2

Step 2: If total testosterone is:

  • <150 ng/dL: Likely hypogonadism (98.9% specificity) 4
  • 150-350 ng/dL: Measure SHBG and calculate free testosterone (mandatory) 2, 4
  • 350-400 ng/dL: Consider SHBG measurement, especially if age >60 or conditions affecting SHBG present 3, 4
  • >400 ng/dL: Measure SHBG if patient has conditions that elevate SHBG (aging, HIV, cirrhosis, hyperthyroidism) 2, 3

Step 3: Calculate free testosterone using total testosterone, SHBG, and albumin 2

Step 4: Diagnose hypogonadism when free testosterone <64 pg/mL (220 pmol/L) or <6.5 ng/dL with consistent symptoms 2, 3

Critical Pitfalls

The most common error is relying solely on total testosterone in older men. After age 60, SHBG increases substantially, and 52.5% of men over 60 have elevated SHBG 3. This creates a scenario where total testosterone appears normal but free (bioavailable) testosterone is deficient.

SHBG itself correlates with hypogonadal symptoms independently of total testosterone. Higher SHBG is associated with more severe hypogonadal symptoms (ANDROTEST score), lower PSA, and lower hematocrit—all objective markers of reduced testosterone bioactivity 6. The optimal SHBG cutoff for predicting symptomatic hypogonadism is 44.40 nmol/L 7.

Why This Matters

The free hormone hypothesis is supported by evidence showing that elevated gonadotropins (LH/FSH) correlate with low free testosterone even when total testosterone is normal or elevated, confirming that free testosterone—not total testosterone—drives the hypothalamic-pituitary-testicular feedback loop 5. This validates that measuring only total testosterone misses clinically significant hypogonadism, particularly in aging men with elevated SHBG.

Related Questions

When is free testosterone measurement preferred over total testosterone for diagnosing male hypogonadism?
Can high testosterone, high Sex Hormone-Binding Globulin (SHBG), and high Luteinizing Hormone (LH) levels indicate compensated hypogonadism?
In a male patient with a free testosterone of 2.7 pg/mL and a total testosterone of 392 ng/dL, what does this indicate and what are the recommended next steps?
For an adult male with total testosterone 341 ng/dL and normal LH, FSH, and SHBG, is a free testosterone level of 50.8 pg/mL within the normal range and does it indicate a need for testosterone replacement therapy?
Could my recent low libido and erectile dysfunction be due to elevated sex hormone‑binding globulin causing low free testosterone despite a total testosterone of ~40 nmol/L, and what evaluation and treatment should I pursue?
For a patient with recurrent E. coli infection resistant to ceftriaxone after completing a 7‑day course of meropenem IV three times daily two weeks ago, what is the appropriate duration of ceftriaxone therapy and should the dose be 1 g or 2 g daily?
What are the evidence‑based measures to prevent vascular disease in adults with diabetes?
How should I manage a 19‑year‑old patient with a 7‑day history of epigastric pain that occurs with eating or drinking, normal bowel movements and urine output, and a past medical history of ichthyosis vulgaris, Behçet disease (oral ulcers, folliculitis, pyoderma, treated with doxycycline), Gilbert's syndrome, mild scoliosis, and chronic constipation, who is currently taking colchicine 500 µg twice daily, betamethasone mouthwash, benzydamine (Difflam), doxycycline 100 mg once daily, vitamin C, B‑complex, vitamin B12, magnesium, coenzyme Q10, and is intolerant to methotrexate?
How is arterial hypertension diagnosed in children?
Can pulmonary hypertension cause tricuspid regurgitation?
What is the recommended treatment for acute coronary syndrome in a patient using cocaine?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.